These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Acute wheeze in the pediatric population: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Katz MA; Marangu D; Attia EF; Bauwens J; Bont LJ; Bulatovic A; Crane J; Doroshenko A; Ebruke BE; Edwards KM; Fortuna L; Jagelaviciene A; Joshi J; Kemp J; Kovacs S; Lambach P; Lewis KDC; Ortiz JR; Simões EAF; Turner P; Tagbo BN; Vaishnavi V; Bonhoeffer J; Vaccine; 2019 Jan; 37(2):392-399. PubMed ID: 28483201 [No Abstract] [Full Text] [Related]
14. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M; Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566 [No Abstract] [Full Text] [Related]
15. Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Woerner A; Pourmalek F; Panozzo C; Pileggi G; Hudson M; Caric A; Abraham S; Varricchio F; Velasco C; Oleske J; Bauwens J; Bonhoeffer J; Vaccine; 2019 Jan; 37(2):384-391. PubMed ID: 30342899 [No Abstract] [Full Text] [Related]
16. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS; Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144 [No Abstract] [Full Text] [Related]
17. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Kochhar S; Assis DN; Mack C; Izurieta HS; Muratori L; Munoz A; Nordenberg D; Gidudu JF; Blau EF; Vierling JM Vaccine; 2024 Mar; 42(7):1812-1825. PubMed ID: 38368225 [TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Rüggeberg JU; Gold MS; Bayas JM; Blum MD; Bonhoeffer J; Friedlander S; de Souza Brito G; Heininger U; Imoukhuede B; Khamesipour A; Erlewyn-Lajeunesse M; Martin S; Mäkelä M; Nell P; Pool V; Simpson N; Vaccine; 2007 Aug; 25(31):5675-84. PubMed ID: 17448577 [No Abstract] [Full Text] [Related]
19. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I; Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484 [No Abstract] [Full Text] [Related]
20. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K; Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552 [No Abstract] [Full Text] [Related] [Next] [New Search]